Predominant Tubular Interleukin-18 Expression in Polyomavirus-Associated Nephropathy

Transplantation

Volumn 100, Issue 10, 2016, Pages e88-e95

  Stokman, Geurt ^a   Kers, Jesper ^a   Yapici, Ünsal ^a   Hoelbeek, Joris J ^a   Claessen, Nike ^a   De Boer, Onno J ^a   Netea, Mihai G ^b   Hilbrands, Luuk ^b   Bemelman, Fréderike J ^a   Ten Berge, Ineke J M ^a   Florquin, Sandrine ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; INTERLEUKIN 18; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENETIC TRANSCRIPTION; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MACROPHAGE; MALE; POLYOMAVIRUS ASSOCIATED NEPHROPATHY; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL MEDIATED REJECTION; BK VIRUS; GENETICS; IMMUNOLOGY; MIDDLE AGED; VIRUS INFECTION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BK VIRUS; FEMALE; GRAFT REJECTION; HUMANS; INTERLEUKIN-18; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; RECEPTORS, CELL SURFACE; TRANSCRIPTION, GENETIC; TUMOR VIRUS INFECTIONS;

EID: 84957837329     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001086     Document Type: Article

References (36)

1. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999;67:918-922.
2. Shah KV. Polyomaviruses. In: Fields BN, Knipe DM, Howley PM, et al., eds. Virology. 3rd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1996:2027-2043.
3. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003;71:115-123.
4. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79:1277-1286.
5. van Aalderen MC, Heutinck KM, Huisman C, et al. BK virus infection in transplant recipients: clinicalmanifestations, treatment options and the immune response. Neth J Med. 2012;70:172-183.
6. Ahuja M, Cohen EP, Dayer AM, et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. Transplantation. 2001;71:896-899.
7. Mannon RB, Hoffmann SC, Kampen RL, et al. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant. 2005;5:2883-2893.
8. Li X, Sun Q, Chen J, et al. Immunophenotyping in BK virus allograft nephropathy distinct from acute rejection. Clin Dev Immunol. 2013;2013: 412902.
9. Yapici U, Kers J, Slavujevic-Letic I, et al. Intragraft Blood Dendritic Cell Antigen-1-PositiveMyeloid Dendritic Cells Increase during BK Polyomavirus-Associated Nephropathy. J AM Soc Nephrol. 2016;8:2502-2510.
10. Heutinck KM, Rowshani AT, Kassies J, et al. Viral double-stranded RNA sensors induce antiviral, pro-inflammatory, and pro-apoptotic responses in human renal tubular epithelial cells. Kidney Int. 2012;82:664-675.
11. van den Brand M, Hoevenaars BM, Sigmans JH, et al. Sequential immunohistochemistry: a promising new tool for the pathology laboratory. Histopathology. 2014;65:651-657.
12. Nickeleit V, Mengel M, Colvin BC. Renal transplant pathology. In: Jennette JC, Olson JL, Silva FG, et al., eds. Heptinstall's Pathology of the Kidney. 7th ed. Philadelphia, PA: Wolters Kluwer; 2015:1321-1459.
13. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14:272-283.
14. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant. 2010;10:464-471.
15. Hirsch HH, Randhawa P, AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013; 13(Suppl 4):179-188.
16. Ruijter JM, Ramakers C, Hoogaars WM, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 2009;37:e45.
17. Tuomi JM, Voorbraak F, Jones DL, et al. Bias in the Cq value observed with hydrolysis probe based quantitative PCR can be corrected with the estimated PCR efficiency value. Methods. 2010;50: 313-322.
18. Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676-682.
19. Thévenaz P, Ruttimann UE, Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process. 1998;7: 27-41.
20. Ruifrok AC, Johnston DA. Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol. 2001;23:291-299.
21. Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;16:3046-3052.
22. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70:199-203.
23. Striz I, Krasna E, Honsova E, et al. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett. 2005;99: 30-35.
24. Gauer S, Sichler O, Obermüller N, et al. IL-18 is expressed in the intercalated cell of human kidney. Kidney Int. 2007;72:1081-1087.
25. Netea MG, van de Veerdonk FL, van der Meer JW, et al. Inflammasomeindependent regulation of IL-1-family cytokines. Annu Rev Immunol. 2014;33:49-77.
26. Novick D, Kim S, Kaplanski G, et al. Interleukin-18, more than a Th1 cytokine. Semin Immunol. 2013;25:439-448.
27. Homs S, Mansour H, Desvaux D, et al. Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant. 2009;9:1230-1236.
28. Loverre A, Divella C, Castellano G, et al. T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. Transpl Int. 2011;24:233-242.
29. SunQ, Cheng D, Zhang M, et al. Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection. J Am Soc Nephrol. 2011;22:246-252.
30. Dinarello CA, Novick D, Kim S, et al. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289.
31. Sirén J, Pirhonen J, Julkunen I, et al. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29. J Immunol. 2005;174:1932-1937.
32. Grenfell S, Smithers N, Miller K, et al. Receptor-mediated endocytosis and nuclear transport of human interleukin 1 alpha. Biochem J. 1989;264:813-822.
33. Masamune A, Watanabe T, Kikuta K, et al. Nuclear expression of interleukin-33 in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2010;299:G821-G832.
34. Roth J, Goebeler M, Erpenstein U, et al. Differential regulation of the macrophage-specific surface antigen RM3/1 by cyclosporine, azathioprine, and dexamethasone. Transplantation. 1994;57:127-133.
35. Ikezumi Y, Suzuki T, Yamada T, et al. Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury. Pediatr Nephrol. 2015;30:1007-1017.
36. Zhao L, David MZ, Hyjek E, et al. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Clin J Am Soc Nephrol. 2015;10:54-62.